Cross Sectional Analysis of Healthcare for Psoriasis in 4 European Countries

Study Overview
=================
Brief Summary
-----------------
Analysis of barriers in psoriasis care from the patient's and the physician's perspective and generation of scientific data on the quality of health care in Denmark, Poland, Spain, and Germany

Detailed Description
-----------------
Cross-sectional, non-interventional study on healthcare for psoriasis in patients and their treating physicians. Clinical data on severity as well as subjective estimates on disease burden, quality of life etc. will be collected. Data collection is planned at multiple, representative sites in fourEuropean countries with different healthcare systems with the aim to identify system-dependent and -independent barriers in guideline-compliant psoriasis care.

Official Title
-----------------
PsoBarrierEU - Barrier Analysis of Guideline-Compliant Healthcare for Psoriasis in Europe

Conditions
-----------------
Psoriasis

Intervention / Treatment
-----------------
* Other: non-interventional


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: clinically diagnosed psoriasis vulgaris age ≥ 18 written informed consent Exclusion Criteria: lack of mental, physical or linguistic ability to participate in a questionnaire survey

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| psoriasis patients in Denmark<br>non-interventional survey study in psoriasis patients in daily practice care | Other: non-interventional<br>* non-interventional survey study<br>* Other names: non-interventional survey study;|
| psoriasis patients in Spain<br>non-interventional survey study in psoriasis patients in daily practice care | Other: non-interventional<br>* non-interventional survey study<br>* Other names: non-interventional survey study;|
| psoriasis patients in Poland<br>non-interventional survey study in psoriasis patients in daily practice care | Other: non-interventional<br>* non-interventional survey study<br>* Other names: non-interventional survey study;|
| psoriasis patients in Germany<br>non-interventional survey study in psoriasis patients in daily practice care | Other: non-interventional<br>* non-interventional survey study<br>* Other names: non-interventional survey study;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Percentage of patients with severe disease receiving systemic treatment |  | Baseline | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Psoriasis Area and Severity Index (PASI) | Psoriasis disease severity, measured by validated instrument | Baseline | 
| Body Surface Area (BSA) | Psoriasis-affected body area, measured by physician estimate | Baseline | 
| Dermatology Life Quality Index (DLQI) | Quality of life assessment in dermatologic patients, measured by validated quality of life instrument | Baseline | 
| EuroQuol (EQ-5D) | generic quality of life assessment, measured by validated visual analogue scale | Baseline | 
| Percentage of patients with comorbidities receiving treatment. |  | Baseline |